Schedule 13D ownership disclosure
ESSA PHARMA INC
Security class unavailable · CUSIP: 29668H104
Event date: 2016-01-14
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 13.8000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-16-437111
- Form type
- SC 13D
- Filer
- Clarus Lifesciences III, L.P.
- CIK
- CIK 1597143
- Filed
- Jan 26, 2016
- Reporting period
- Jan 14, 2016
- Description
- Schedule 13D beneficial ownership